SCHEMBL27643029

SCHEMBL27643029

CC(=O)C1CC(CO)N(N)C1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ENGASE Q8NFI3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16217602 0.71 — —
SCHEMBL17972860 0.69 POLB (0.33) —
SCHEMBL761653 0.62 — —
SCHEMBL4368534 0.61 MMP2 (0.50) —
SCHEMBL30476580 0.61 MMP2 (0.50) —
SCHEMBL8303532 0.61 SMN1; SMN2 (0.43) ENGASE
SCHEMBL8303525 0.61 SMN1; SMN2 (0.43) ENGASE
SCHEMBL89463 0.61 ALDH1A1 (0.37) —
SCHEMBL22834149 0.61 — —
SCHEMBL14381065 0.60 BRD4 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1852712-B Dual NK1/NK3 antagonists for treating schizophrenia HOFFMANN LA ROCHE 2010-06-09 — — CN disclosed
CN-1852712-A Dual NK1/NK3 antagonists for treating schizophrenia HOFFMANN LA ROCHE (CH) 2006-10-25 — — CN disclosed
Send feedback